Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II

A. Dietz*, G. Wichmann, T. Kuhnt, L. Pfreundner, R. Hagen, M. Scheich, O. Kölbl, M. G. Hautmann, J. Strutz, F. Schreiber, U. Bockmühl, V. Schilling, P. Feyer, M. De Wit, G. Maschmeyer, M. Jungehülsing, U. Schroeder, B. Wollenberg, C. Sittel, M. MünterT. Lenarz, J. P. Klussmann, O. Guntinas-Lichius, C. Rudack, H. T. Eich, T. Foerg, S. Preyer, M. Westhofen, H. J. Welkoborsky, D. Esser, D. Thurnher, S. Remmert, H. Sudhoff, M. Görner, J. Bünzel, V. Budach, S. Held, M. Knödler, F. Lordick, S. Wiegand, K. Vogel, A. Boehm, M. Flentje, U. Keilholz

*Korrespondierende/r Autor/-in für diese Arbeit
19 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science